What is the current Price Target for the AbbVie stock?

The average AbbVie target price is $214.70. This is 11.62% higher than the current stock price. The highest price target is 30.50%, the lowest is -10.06%. 23 Analysts have issued a price target AbbVie 2026 .

How high will the AbbVie stock rise?

No reliable answer can be given as to how high the AbbVie stock will rise. The performance of stocks, including the AbbVie stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the AbbVie stock today?

The performance of AbbVie stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the AbbVie stock fall?

The decline in AbbVie stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

AbbVie Forecast, price target & analysts

$192.34

3.38% yesterday

NYSE, Apr 28, 10:10 pm CET

ISIN

US00287Y1091

Symbol

ABBV

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

AbbVie Target price 2025 - Analyst rating & recommendation

AbbVie Classifications & Recommendation:

Buy

62%

Hold

34%

Sell

AbbVie Price Target

Target Price	$214.70
Price	$192.34
Potential	11.62% register free of charge
Number of Estimates	23

	23 Analysts have issued a price target AbbVie 2026 . The average AbbVie target price is $214.70. This is 11.62% register free of charge higher than the current stock price. The highest price target is $251.00 30.50% register free of charge , the lowest is $173.00 10.06% register free of charge .
	A rating was issued by 29 analysts: 18 Analysts recommend AbbVie to buy, 10 to hold and 1 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the AbbVie stock has an average upside potential 2026 of 11.62% register free of charge . Most analysts recommend the AbbVie stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Revenue Billion $	56.33	59.78
	3.71%	6.12%
EBITDA Margin	44.40%	48.11%
	9.95%	8.36%

22 Analysts have issued a sales forecast AbbVie 2025 . The average AbbVie sales estimate is

Unlock

. This is

Unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics:

2024	$56.3b	3.71%
2025	$59.8b 6.12% Unlock
2026	$64.6b 8.01% Unlock
2027	$68.9b 6.76% Unlock
2028	$73.7b 6.92% Unlock
2029	$77.3b 4.90% Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	2.39	6.73
	12.13%	181.59%
P/E		28.57

9 Analysts have issued a AbbVie forecast for earnings per share. The average AbbVie EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$2.39	12.13%
2025	$6.73 181.59% Unlock
2026	$10.23 52.01% Unlock
2027	$10.97 7.23% Unlock
2028	$13.02 18.69% Unlock
2029	$14.90 14.44% Unlock

Current	81.82	39.43%
2025	28.57 65.08% Unlock
2026	18.81 34.16% Unlock
2027	17.53 6.80% Unlock
2028	14.77 15.74% Unlock
2029	12.91 12.59% Unlock

AbbVie...

Current AbbVie Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Morgan Stanley	Locked ➜ Locked	Locked	Apr 28 2025
Evercore ISI Group	Locked ➜ Locked	Locked	Apr 28 2025
Cantor Fitzgerald	Locked ➜ Locked	Locked	Apr 22 2025
Guggenheim	Locked ➜ Locked	Locked	Apr 17 2025
Morgan Stanley	Locked ➜ Locked	Locked	Apr 09 2025
Wells Fargo	Locked ➜ Locked	Locked	Mar 05 2025
B of A Securities	Locked ➜ Locked	Locked	Mar 04 2025

Analyst Rating	Date
Locked Morgan Stanley: Locked ➜ Locked	Apr 28 2025
Locked Evercore ISI Group: Locked ➜ Locked	Apr 28 2025
Locked Cantor Fitzgerald: Locked ➜ Locked	Apr 22 2025
Locked Guggenheim: Locked ➜ Locked	Apr 17 2025
Locked Morgan Stanley: Locked ➜ Locked	Apr 09 2025
Locked Wells Fargo: Locked ➜ Locked	Mar 05 2025
Locked B of A Securities: Locked ➜ Locked	Mar 04 2025

Discover more stocks with a high price target

Alibaba Group Holding Ltd 38.45%

Infineon 37.09%

Walt Disney 35.50%

BioNTech SE - ADR 34.08%

Adyen 32.48%

Amazon.com 32.17%

Coinbase Global, Inc. 31.52%

Tencent Holdings Ltd. 29.25%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now